Reimbursement Dispute Between Novitas And iRhythm Hits An Impasse

The ongoing dispute between payers and manufacturers over Medicare reimbursement rates for continuous cardiac monitoring is unlikely not be resolved soon.

Since the end of January, a consortium of monitoring device companies, led by iRhythm Technologies, has been working with Texas-based Medicare Administrative Contractor Novitas to agree on Medicare reimbursement rates for long-term continuous electrocardiogram (ECG) monitoring. So far, the two sides have not reached an agreement